Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07275476

Pregnancy and Fibrin Clot Properties

Fibrin Clot Properties and Thrombin Generation in Pregnancy Women With and Without Obstetric Complications.

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Jagiellonian University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

1. The structure of fibrin clot and thrombin generation may vary between trimesters of pregnancy. 2. Unfavorably altered fibrin clot properties along with enhanced thrombin generation may lead to the development of complications during pregnancy such as TE and hypertensive disorders. 3. The application of machine learning techniques may help to identify previously undetected phenotypes with increased risk of TE and hypertensive disorders during pregnancy.

Detailed description

Taken together, the integration of both fibrin clot properties and thrombin generation markers in pregnant women using modern science techniques may reveal new mechanisms explaining the relationship between altered fibrin clot properties and certain pregnancy complications. Moreover, it may help to identify new clot phenotypes of potential clinical significance, indicating prothrombotic risk or elevated chance of development of hypertensive disorders during pregnancy. Specific working hypotheses: 1. The structure of fibrin clot and thrombin generation may vary between trimesters of pregnancy. 2. Unfavorably altered fibrin clot properties along with enhanced thrombin generation may lead to the development of complications during pregnancy such as TE and hypertensive disorders. 3. The application of machine learning techniques may help to identify previously undetected phenotypes with increased risk of TE and hypertensive disorders during pregnancy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTanalysis of fibrin clot properties and thrombin generationdetermination of fibrin clot properties and thrombin generation

Timeline

Start date
2025-11-28
Primary completion
2026-01-01
Completion
2027-12-01
First posted
2025-12-10
Last updated
2025-12-10

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT07275476. Inclusion in this directory is not an endorsement.